comparemela.com

Latest Breaking News On - Redhill biopharma company profile - Page 3 : comparemela.com

RedHill Biopharma Ltd. (NASDAQ:RDHL) Sees Significant Growth in Short Interest

RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 7,700 shares, an increase of 102.6% from the August 15th total of 3,800 shares. Based on an average trading volume of 217,300 shares, […]

Redhill-biopharma
Millennium-management
Nasdaq
Redhill-biopharma-company-profile
Morgan-stanley
Redhill-biopharma-ltd
Renaissance-technologies
Virtu-financial
Get-free-report
Hill-biopharma
Hill-biopharma-ltd
Redhill-biopharma-daily

RedHill Biopharma (NASDAQ:RDHL) Share Price Passes Below 200-Day Moving Average of $3.49

RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $3.49 and traded as low as $0.93. RedHill Biopharma shares last traded at $0.95, with a volume of 69,182 shares trading hands. Analysts Set New Price Targets […]

Redhill-biopharma
Renaissance-technologies
Morgan-stanley
Redhill-biopharma-ltd
Millennium-management
Virtu-financial
Nasdaq
Redhill-biopharma-company-profile
Get-free-report
Hill-biopharma
Hill-biopharma-stock-down
Hill-biopharma-ltd

RedHill Biopharma (NASDAQ:RDHL) Lifted to Buy at StockNews.com

StockNews.com upgraded shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. RedHill Biopharma Stock Down 0.8 % Shares of RDHL stock opened at $1.19 on Friday. RedHill Biopharma has a 12 month low of $1.16 and a 12 month high […]

Redhill-biopharma
Armistice-capital
Redhill-biopharma-ltd
Redhill-biopharma-company-profile
Renaissance-technologies
Millennium-management
Morgan-stanley
Free-report
Hill-biopharma-stock-down
Hill-biopharma
Hill-biopharma-ltd
Redhill-biopharma-daily

StockNews.com Upgrades RedHill Biopharma (NASDAQ:RDHL) to Buy

RedHill Biopharma (NASDAQ:RDHL – Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Saturday. RedHill Biopharma Stock Performance NASDAQ:RDHL opened at $1.20 on Friday. The stock’s fifty day moving average is $2.06 and its two-hundred day moving average is $5.07. RedHill […]

Redhill-biopharma
Redhill-biopharma-ltd
Redhill-biopharma-company-profile
Blackrock-inc
Millennium-management
Nasdaq
Renaissance-technologies
Virtu-financial
Free-report
Hill-biopharma
Hill-biopharma-ltd
Redhill-biopharma-daily

RedHill Biopharma Ltd. (NASDAQ:RDHL) Sees Large Decline in Short Interest

RedHill Biopharma Ltd. (NASDAQ:RDHL – Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 28,200 shares, a decline of 64.5% from the May 31st total of 79,400 shares. Based on an average daily volume of 91,700 shares, the […]

Redhill-biopharma
Redhill-biopharma-company-profile
Blackrock-inc
Virtu-financial
Redhill-biopharma-ltd
Armistice-capital
Nasdaq
Millennium-management
Morgan-stanley
Free-report
Hill-biopharma
Hill-biopharma-ltd

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.